“This means that we can also accelerate vaccination campaigns in our country,” he commented in a first reaction.
The European Commission has reached an agreement with BioNTech and Pfizer, developers and manufacturers of the first coronavirus vaccine authorized on the European market, to “extend” the pre-order contract for the benefit of the 27 Member States. Europe will be able to count on an additional 300 million doses of vaccine, in addition to the 300 million doses included in the initial agreement, European Commission President Ursula von der Leyen told a news conference on Friday morning.
“This is a game changer, because it means that we will also be able to accelerate vaccination in our country and protect more people more quickly,” the Belgian prime minister said in a statement.
Doubling the number of Pfizer vaccines, De Croo said, shows that the European approach works.
“If small Member States like Belgium had to conduct these negotiations on their own, we would never have had so much access to vaccines. I would have had to bet on one or two vaccines last year, not knowing if development would lead to Thanks to the European program, we already have access to two effective vaccines, Pfizer and Moderna, and two other vaccines, AstraZeneca and Johnson & Johnson, are in the final stages, and our country has played a crucial role in many of them. of these vaccines and we could be a little more proud of them, ”said Alexander De Croo.